These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis. Polis MA. J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S3-10. PubMed ID: 1318365 [Abstract] [Full Text] [Related]
25. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. Peters M, Timm U, Schürmann D, Pohle HD, Ruf B. Clin Investig; 1992 May; 70(5):456-8. PubMed ID: 1318131 [Abstract] [Full Text] [Related]
26. The treatment of cytomegalovirus in AIDS--more than meets the eye. Hirsch MS. N Engl J Med; 1992 Jan 23; 326(4):264-6. PubMed ID: 1309391 [No Abstract] [Full Text] [Related]
27. Why was treatment of cytomegalovirus retinitis randomized? Salit IE. Ann Intern Med; 1992 Apr 01; 116(7):604-5. PubMed ID: 1311907 [No Abstract] [Full Text] [Related]
28. Treatment of CMV retinitis. Bachman DM. N Engl J Med; 1992 Jun 18; 326(25):1702; author reply 1702-3. PubMed ID: 1317012 [No Abstract] [Full Text] [Related]
30. Foscarnet for CMV retinitis. Wood CA. Lancet; 1992 Feb 22; 339(8791):501. PubMed ID: 1346861 [No Abstract] [Full Text] [Related]
31. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Jacobson MA, O'Donnell JJ, Mills J. Antimicrob Agents Chemother; 1989 May 22; 33(5):736-41. PubMed ID: 2546490 [Abstract] [Full Text] [Related]
32. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Chrisp P, Clissold SP. Drugs; 1991 Jan 22; 41(1):104-29. PubMed ID: 1706982 [Abstract] [Full Text] [Related]